4-(4-Nitrophenyl)morpholin-3-one
and 4-(4-aminophenyl) morpholin-3-one
are the key intermediates for rivaroxaban synthesis. A facile and
economically efficient process has been developed for the preparation
of these intermediates. Excellent yield of 4-(4-nitrophenyl)morpholine
is obtained by condensing 4-chloro nitrobenzene and morpholine, and
4-(4-nitrophenyl)morpholine is oxidized using inexpensive sodium chlorite
to achieve a good yield of the corresponding 4-(4-nitrophenyl)morpholin-3-one.
Finally, the key intermediate of rivaroxaban, 4-(4-aminophenyl) morpholin-3-one,
is achieved by the iron(III)-catalyzed reduction of the nitro group
with aqueous hydrazine. No high-cost materials were used, and the
process did not require column purification.
By using cheap and innocuous sodium chlorite, a series of tertiary amines have been oxidized to the corresponding lactams with good selectivity and high yield. In this method, neither transition-metal catalyst nor oxidant was used. In the oxidation step, the pH of the sodium chlorite was precisely adjusted to pH around 6 using CO2, such pH is a compromise between oxidative properties, chemical stability, and unwanted precipitation. In addition, buffer salts are not necessary, which allows this oxidation reaction to be performed under safe and environmentally benign conditions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.